Sensitivity of cervical cytology in endometrial cancer detection in a tertiary hospital in Spain

Introduction Cervical cytology is a well‐stablished cervical cancer screening method. However, due to the anatomical continuity of the genital tract, it can also detect signs of endometrial disease. Our aim was to estimate the sensitivity of cervical cytology in endometrial cancer detection and prog...

Full description

Saved in:
Bibliographic Details
Published in:Cancer medicine (Malden, MA) Vol. 10; no. 19; pp. 6762 - 6766
Main Authors: Frias‐Gomez, Jon, Tovar, Eva, Vidal, August, Murgui, Lluis, Ibáñez, Raquel, Peremiquel‐Trillas, Paula, Paytubi, Sonia, Baixeras, Nuria, Zanca, Alba, Ponce, Jordi, Pineda, Marta, Brunet, Joan, de Sanjosé, Silvia, Bosch, Francesc Xavier, Matias‐Guiu, Xavier, Alemany, Laia, Costas, Laura
Format: Journal Article
Language:English
Published: United States John Wiley & Sons, Inc 01-10-2021
John Wiley and Sons Inc
Wiley
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction Cervical cytology is a well‐stablished cervical cancer screening method. However, due to the anatomical continuity of the genital tract, it can also detect signs of endometrial disease. Our aim was to estimate the sensitivity of cervical cytology in endometrial cancer detection and prognosis in a large population over a 30‐year period in a large academic tertiary hospital in Spain. Methodology We performed a search for women diagnosed with endometrial cancer from 1990 to 2020, who were surgically treated and had a previous cervical cytology result. Information Technologies Department databases from Bellvitge University Hospital and the Screenwide case–control study's database were used. Cervical cytology results were classified as abnormal when squamous lesions, glandular atypia or malignant cells were identified. Results Overall, we evaluated 371 women with endometrial cancer and a documented cervical cytology performed within 3 years previous to surgical treatment. Overall, the sensitivity of cervical cytology for endometrial cancer detection was 25.6%. Several clinico‐pathological characteristics, such as non‐endometrioid histology and a higher stage, were correlated with higher sensitivity. Discussion We observed a low sensitivity of cervical cytology to effectively diagnose endometrial cancer. However, recent technological advances using genomics and epigenomics may offer a promising perspective to detect endometrial cancer with high sensitivity in these cervical specimens. Cervical cytology sensitivity for endometrial cancer was 25.6%. Several clinico‐pathological factors, such as non‐endometrioid histology and a higher stage, were correlated with higher sensitivity.
Bibliography:Funding information
This work was conducted with the contribution of the Carlos III Health Institute through projects PIE16/00049, PI17/01179 and PI19/01835, as well as through CIBERESP CB06/02/0073 and CIBERONC CB16/12/00401, and CM19/00216, FI20/00031, MV20/00029 co‐financed by the European Regional Development Fund ERDF, a way to build Europe. It also counts with the support of the Secretariat for Universities and Research of the Department of Business and Knowledge of the Generalitat de Catalunya, grants to support the activities of research groups 2017SGR01085, 2017SGR01718 and 2017SGR00735 and also with funding from the Health Department of the Generalitat de Catalunya (PERIS SLT006/17/76). We thank CERCA Programme/Generalitat de Catalunya for institutional support.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2045-7634
2045-7634
DOI:10.1002/cam4.4217